TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science October 28, 1994
TCL Archive DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI October 2, 1981
TCL Archive On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials September 17, 1999
